Please login to the form below

Not currently logged in
Email:
Password:

EAMS

This page shows the latest EAMS news and features for those working in and with pharma, biotech and healthcare.

Latest news

More from news
Approximately 11 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Can UK pharma rise to the post-Brexit challenge? Can UK pharma rise to the post-Brexit challenge?

    4.The Early Access to Medicine Scheme (EAMS) could be adopted more quickly by the NHS, to achieve patient access to new medicines more rapidly.

  • Lighting the way Lighting the way

    Ultimately the government says the Review's recommendatiosn have the potential to cut four years from the process, through a funded Early Access to Medicines Scheme (EAMS) alongside more speedy technology

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    in the Early Access to Medicines Scheme (EAMS), streamlining health technology assessment and facilitating commissioning and adoption.

  • Curbing the rise of drug resistance Curbing the rise of drug resistance

    The anti-microbial sector would also benefit greatly from enhanced patent protection and faster regulatory approval, via new regulatory programmes such as the UK's Early Access to Medicines Scheme (EAMS)

  • Creating a 21st century life sciences ecosystem Creating a 21st century life sciences ecosystem

    His plan to encourage this is the early access to medicines scheme (EAMS), a new policy set up (and led by Freeman) this year that is looking to speed up the ... He'd rather see all the key stakeholders work together and use the EAMS project, rather than

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics